The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...

Merck reports strong new HIV study results showing non-inferiority of DOR/ISL to Gilead's Biktarvy and secures an EU approval ...

Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

Women are disproportionately affected by HIV, making up nearly half of new infections globally and in India. Stigma, gender ...

The initiative, funded by a $12 million grant from the National Institute on Drug Abuse, will evaluate how people with ...

China has pledged $3.49 million to support HIV prevention services in South Africa over the next two years under a new ...

Activists have sharply criticised the US government’s move to exclude South Africa from receiving HIV prevention medication ...

New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...

The number of new HIV infections in the Netherlands is expected to increase in the coming years, ending a long-running ...

Last year, 444 people in the Netherlands were diagnosed with HIV, the virus that can cause AIDS. Almost 20 years ago, there ...